Prof. PeptideProf. Peptide

Does BPC-157 need to be cycled?

Clinics run BPC-157 in courses rather than continuously: most often 4 to 8 weeks, then a break of 2 to 4 weeks before another course. Longer courses, of 8 to 12 weeks, are described for chronic conditions. No human study has tested a course length, a break between courses, or long-term use.

  • FAQ
  • Recovery & Tissue Repair
  • Prof. Peptide evidence level: Human observational
  • Research use only

Course lengths clinics publish

  • 4–8 weeks for acute injuries and 8–12 weeks for chronic conditions1.
  • Typically 4 to 8 weeks depending on the indication, with a break between cycles before repeating; one cycle runs a month of 20 injections, 5 days on and 2 days off2.
  • Once or twice a day for 4 to 8 weeks, then a break3.
  • Some providers use shorter, more frequent cycles, 4 to 6 weeks on and 2 weeks off, rather than extended continuous use4.

Why clinics stop

One clinician stops BPC-157 at week 6 after rotator-cuff repair, and writes that a protocol running for 3 to 6 months without a mechanistic rationale is a signal to ask hard questions5. Clinic cautions on longer use sit with the side effects: one clinic lists hot flashes, blood-pressure swings and liver and kidney problems, which it says appear mostly with extended use6.

What the human studies tested

None of the three published human studies tested a course. One reviewed knee-joint injections, one used a single injection procedure, and one gave infusions on two consecutive days789. The long-term safety of BPC-157 in people is unknown10.

Each clinic's dose and course are set out in How is BPC-157 dosed?.

Research status

Human observationalLevel 3 of 4
Prof. Peptide’s evidence level records the highest study design a compound has been examined under, not whether the results were good. The full method is on the methodology page.

References

  1. Beyond Stem Cells Medical Spa, Littleton, Colorado. Best way to take BPC-157: the complete guide to dosing and administration; read October 26 and 29, 2026.Source →
  2. Perfect B Aesthetic Medicine, Doral, Florida. BPC-157 dosage protocol; read October 26 and 29, 2026.Source →
  3. BPC-157 Dosage Guide: Complete Protocol for Safe AdministrationClinicBeverly Hills Rejuvenation Center (bhrcenter.com). Read October 25, 2026. Clinician-published protocol, cited for its own published dose, schedule, route and the side effects it lists (which it labels anecdotal).bhrcenter.com →
  4. Patrick Taylor, MD. BPC-157: The Complete Evidence-Based Guide. PeptideWise (drpattaylor.com), linked to Live Vital, Draper, Utah. Undated; read October 27, 2026.Source →
  5. Patrick J. Denard, MD. Why I Stop BPC-157 at Week 6 After Rotator Cuff Repair. Oregon Shoulder Institute, Medford, Oregon. Undated; read October 27, 2026.Source →
  6. Diane Brzezinski, DO. Practice article on BPC-157 for gut health and injury recovery. Naples, Florida (drbnaples.com). Published April 11, 2023; read October 27, 2026.Source →
  7. Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainHuman, retrospectiveLee E, Padgett B. Altern Ther Health Med. 2021;27(4):8-13.Key finding: Phone follow-up of 16 of 17 patients after a knee-joint injection: 14 of 16 reported significant improvement (11 of 12 given BPC-157 alone, 3 of 4 given it with thymosin beta-4); no control group or validated scale.PubMed 34324435 →
  8. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot StudyHuman pilotLee E, Walker C, Ayadi B. Altern Ther Health Med. 2024;30(10):12-17.Key finding: 12 women given one 10 mg injection into the bladder wall at cystoscopy: 10 reported complete resolution and 2 reported 80% improvement; no adverse events; no control group.PubMed 39325560 →
  9. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot StudyHuman pilotLee E, Burgess K. Altern Ther Health Med. 2025;31(5):20-24.Key finding: 2 adults given 10 mg then 20 mg by infusion on consecutive days showed no change in heart, liver, kidney, thyroid or glucose markers; no side effects reported. Both had received intravenous BPC-157 before.PubMed 40131143 →
  10. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safetySystematic reviewPoolton JT, Minett J, Kazmi A. Acta Orthop Belg. 2026;92(3).Key finding: Searching to June 2026 found 3 human studies with 30 people in all (knee 16, bladder 12, intravenous safety 2), all of poor quality; certainty of evidence rated very low.PubMed 42885452 →DOI →

More on this compound

For other common questions regarding BPC-157, see the full BPC-157 profile.

Where to Buy

Capstone Peptides

✓ Lab & COAs Verified🇺🇸 US
50% off
Capstone Peptides logo

Ion Peptide

✓ Lab & COAs Verified🇺🇸 US
15% off
Ion Peptide logo

Crush Research

✓ Labs & COAs Verified🇺🇸 US
10% off
Crush Research logo

Research use only. Not medical advice.

We may earn commissions from peptide vendor affiliate links.

Updated